Drug discovery

#Anxiety disorder #Diabetes #Drug development #Drug discovery #Geographic atrophy #HIV #Lung cancer #Oncology

This week in drug discovery (24-28 April)

News round-up for 24-28 April by DDW Digital Content Editor Diana Spencer. Each of our top five stories this week exemplify the scientific curiosity that fuels the drug discovery sector, ultimately leading to better treatments for patients. The stories cover the efforts by research teams to… Read More

#News

#Cloud computing #Drug discovery #Pathology #R&D #Software

Software aiming to improve efficiency of drug R&D 

A cloud-based digital pathology platform has helped a CRO deliver more informed preclinical studies.  Proscia announced that Virscio, a provider of translational research and development services, has deployed Concentriq for Research.   Context  90% of drug candidates fail during clinical trials.1 This… Read More

#News

Amygdala
#Anxiety disorder #Drug discovery #Neuroscience #Preclinical investigations #University of Bristol #University of Exeter

Discovery represents the ‘first step’ to better anti-anxiety drugs

A team of scientists have discovered that modification of a gene in the brain can reduce anxiety levels, offering an exciting novel drug target for anxiety disorders. The discovery, led by researchers at the Universities of Bristol and Exeter in the UK, is published in Nature… Read More

#News

#DNA #Drug discovery #INTEGRA #Laboratory #PCR

eBook: Learn how to become a PCR pro

The term ‘PCR’ has been on everybody’s lips since the outbreak of the Covid-19 pandemic, but only laboratory professionals know how difficult it can be to achieve success with this well-established technique. If your PCR reactions are driving you to despair, look no further than INTEGRA’s comprehensive… Read More

#News

#DNA #Drug discovery #INTEGRA #Laboratory #PCR

How to become a PCR pro

The term ‘PCR’ has been on everybody’s lips since the outbreak of the Covid-19 pandemic, but only laboratory professionals know how difficult it can be to achieve success with this well-established technique. If your PCR reactions are driving you to despair, look no further than INTEGRA’s comprehensive eBook! Learn more… Read More

#Resources

#Absci #AI / data analytics / healthtech / informatics #Antibodies #Artificial intelligence (AI) #Drug discovery #Interview

How generative AI could improve drug discovery

Listen to this article on the DDW Podcast: Absci is a generative artificial intelligence (AI) drug creation company with goals of bringing better biologics to patients more quickly. Here, DDW Editor Reece Armstrong speaks to Sean McClain, the Founder and CEO of Absci about how generative AI… Read More

#Exclusive Content

#Agilent #Biosafety testing #Drug discovery #In vivo #Infographic #Mitochondria

Learn new ways to identify mitochondrial liability

Download this new mitochondrial toxicity infographic by Agilent and discover the benefits of novel in vitro strategies for consumer safety. Drug-induced mitochondrial dysfunction has been linked to compound attrition, organ toxicity, black-box warnings, and market withdrawals. The infographic will help you: Gain an historical perspective on mitochondrial… Read More

#News

#Agilent #Biosafety testing #Drug discovery #In vivo #Infographic #Mitochondria

Learn new ways to identify mitochondrial liability

Download our mitochondrial toxicity infographic and discover the benefits of novel in vitro strategies for consumer safety. Drug-induced mitochondrial dysfunction has been linked to compound attrition, organ toxicity, black-box warnings, and market withdrawals. Our infographic will help you: Gain an historical perspective on mitochondrial toxicity. Understand the importance of testing… Read More

#Intelligence #Resources

#BioInnovation Institute #Drug discovery #Funding #Investment #Start-ups

Global start-ups: where is the innovation?

Listen to this article on the DDW Podcast: DDW takes a look at some key global activity taking place around the world for drug discovery and life sciences start-ups. UK Budget a ‘shot in the arm’ for oncology start-ups Before the UK announced… Read More

#Exclusive Content #Start-up Zone

#AACR 2023 #Cancer research #Cancer vaccine #Drug discovery #Oncology

New podcast episode: DDW Highlights

The latest episode of the DDW Highlights podcast is now available to listen to below. DDW’s Megan Thomas narrates five key stories of the week to keep DDW subscribers up-to-date on the latest industry updates.  The news stories dominating the headlines this week have been the breaking developments in cancer drug… Read More

#News

#AACR 2023 #Cancer research #Cancer vaccine #Drug discovery #Oncology

This week in drug discovery (16-21 April)

News round-up for 16-21 April by DDW Digital Content Editor Diana Spencer. The news stories dominating the headlines this week have been the breaking developments in cancer drug discovery announced at the American Association of Cancer Research (AACR) Annual Meeting, which was held in Florida, US… Read More

#News

#Antibiotics #Cancer vaccine #Drug discovery #HIV #Long Covid #Malaria

This week in drug discovery (10-14 April)

News round-up for 10-14 April by DDW Digital Content Editor Diana Spencer. The headlines getting our attention this week all represent significant breakthroughs in the treatment of various diseases and could make a huge difference to the lives of these patients. Perhaps most significantly,… Read More

#News

#Drug discovery #Fragment-based drug discovery #Liquid chromatography #Mass spectrometry / NMR #SCIEX

How a recent advancement in mass spectrometry supports drug discovery

This paid-for advertorial by SCIEX appeared in DDW Volume 24 – Issue 2, Spring 2023 Imagine having the ability to consistently identify metabolic soft spots from an experiment that uses liquid chromatography coupled to mass spectrometry (LC-MS), reducing the need for additional safety testing in the… Read More

#Exclusive Content

#Clinical trials #Drug discovery

The need for greater diversity in clinical trials  

By Lucy Radley, Senior Vice President, Head of European Regulatory Development at ProPharma Group.  Clinical trials are, undoubtedly, an essential part of the drug development process, providing us with valuable information about the safety and efficacy of new treatments and therapies. However, despite their deep importance to the wellbeing… Read More

#Exclusive Content